The next generation
of antioxidant
Bioavailable, mitochondria-targeted, and built to go where other antioxidants can’t.
Cellular defense at every level
R-dihydrolipoic acid (R-DLA) is a unique, dual-soluble antioxidant—meaning it dissolves in both fat and water—allowing it to travel easily through the bloodstream and penetrate deep into cells. Once inside, it neutralizes harmful oxygen radicals like hydrogen peroxide and superoxide, two major drivers of oxidative stress and inflammation.
Unlike standard alpha lipoic acid, R-DLA carries extra electrons that directly quench cellular damage, while also helping the body produce more glutathione, the master antioxidant. Its ability to protect and energize mitochondria—the powerhouses of our cells—makes R-DLA a powerful ally in preserving energy, supporting resilience, and slowing the cellular wear that comes with age and stress.
Oxidative stress is a root cause
The buildup of oxygen radicals in the body leads to countless chronic symptoms and conditions. Reducing oxidative stress promotes healthy function for critical systems.
Brain
Enhance cognitive function, reduce inflammation, and improve mental clarity.
Glands & Hormones
Boosts metabolic function and sustains energy levels.
Heart
Supports vascular integrity and elasticity, and promotes overall cardiovascular health.
Gut
Alleviates inflammation and reduces hydrogen peroxide in the mitochondria.
Bones & Muscle
Mitigates muscle breakdown, expedites recovery, and improves joint health.
Proof of impact
A 2019 Clinical Case Study conducted to access the effectiveness of R-DLA on oxidative stress, and the alleviation of symptoms in patients with chronic conditions linked to Oxidative Stress such as Ulcerative Colitis. The results of the study are published in the Journal of Inflammatory Bowel Diseases and Disorders.
Clinically Observed Impact on Oxidative Stress and Cellular Inflammation
In a clinical case series involving patients with advanced oxidative stress and persistent inflammation unresponsive to conventional approaches, a combination protocol including oral R-Dihydrolipoic Acid (R-DLA) was observed to significantly reduce biological markers of tissue damage. Over the course of eight weeks, participants experienced improvements in cellular health, epithelial recovery, and inflammation resolution. These results suggest R-DLA may play a meaningful role in supporting redox balance and promoting recovery from oxidative damage at the tissue level.
87%
of participants
Reached normalized scores across symptom, tissue, and endoscopic markers—indicating systemic improvement
85%
of participants
Showed full resolution of tissue-level inflammation, as measured by histological scoring
97%
of participants
Saw a significant biological response, marked by rapid improvement in oxidative-stress-related symptoms
90%
of participants
Average inflammation severity scores fell by over 90% (from 8.6 to 0.8), highlighting potential redox and mitochondrial recovery
4
weeks
Clinical effects were observed as early as 4 weeks, with continued improvement at 8 weeks
- Novel Combination Therapy Induced Histological Remission in Patients with Refractory Ulcerative Colitis. Dr. Jay Pravda, MD. Journal of Inflammatory Bowel Diseases and Disorders. 2019
